|
General Information
|
|
|
Product
|
MAPK15 Antibody
|
|
Description
|
Affinity Purified Mitogen-activated protein kinase 15 Antibody
|
|
Verified Applications
|
ELISA, IP, WB
|
|
Host
|
Rabbit
|
|
Species Cross Reactivity
|
Human, Mouse, Rat
|
|
Immunogen
|
Synthetic peptide taken within amino acid region 500-544 on human Mitogen-activated protein kinase 15.
|
|
Physical Properties
|
|
|
Quantity
|
100 µg
|
|
Volume
|
200 µl
|
|
Concentration
|
0.5 µg/µl in antibody stabilization buffer
|
|
Immunoglobulin
|
IgG
|
|
Form
|
Affinity Purified
|
|
Purification Method
|
Immobilized antigen affinity chromatography
|
|
Clonality
|
Polyclonal
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
ELISA
|
1:10,000
|
|
Immunoprecipitation
|
1:150
|
|
Western Blot
|
1:500
|
|
Protein
|
|
Uniprot #
|
Q8TD08
|
|
Overview
|
In vitro, phosphorylates MBP.
|
|
Molecular Function
|
Kinase, Serine/threonine-protein kinase, Transferase
|
|
Subcellular Location
|
Extracellular region, intracellular, nucleus
|
|
Expression
|
Widely expressed with a maximal expression in lung and kidney.
|
|
Structure
|
The N-terminal region (1-20) is the minimal region necessary for ubiquitination and further proteasomal degradation.
The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases.
|
|
Alternative Nomenclature
|
ERK7 antibody
ERK8 antibody
Extracellular regulated kinase 8 delta antibody
Extracellular signal-regulated kinase 7 antibody
MAP kinase 15 antibody
MAPK 15 antibody
Mitogen activated protein kinase 15 antibody
MK15_HUMAN antibody
|
| |
|
MAPK15 Antibody BIOTIN
MAPK15 Antibody FITC
MAPK15 Blocking Peptide
MAPK15 Positive Control
